We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+0.86%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$43.9B
AUM Growth
+$1.29B
(+3%)
Cap. Flow
+$573M
Cap. Flow
% of AUM
1.31%
Top 10 Holdings %
Top 10 Hldgs %
9.28%
Holding
3,471
New
479
Increased
1,205
Reduced
1,169
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$229M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$212M |
| 3 |
Snowflake
SNOW
|
+$211M |
| 4 |
Lam Research
LRCX
|
+$193M |
| 5 |
CME Group
CME
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$282M |
| 2 |
PepsiCo
PEP
|
+$239M |
| 3 |
Walmart Inc
WMT
|
+$236M |
| 4 |
General Motors
GM
|
+$223M |
| 5 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.57% |
| 2 | Healthcare | 13.05% |
| 3 | Financials | 12.83% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Discretionary | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYRS
2676
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $208K | ﹤0.01% |
40,266
-28,017
| -41% | -$147K |
|
|
RSVR
2677
Reservoir Media
RSVR
$667M
| $208K | ﹤0.01% |
26,280
-21,564
| -45% | -$172K |
|
2678
First Trust NASDAQ ABA Community Bank Index Fund
QABA
$93.2M
| $207K | ﹤0.01% |
4,500
-5,600
| -55% | -$251K |
|
2679
iShares Core S&P Small-Cap ETF
IJR
$112B
| $203K | ﹤0.01% |
1,900
-16,779
| -90% | -$1.8M |
|
2680
Consensus Cloud Solutions
CCSI
$647M
| $203K | ﹤0.01% |
11,790
-52,421
| -82% | -$848K |
|
|
LVTX
2681
DELISTED
LAVA Therapeutics
LVTX
| $202K | ﹤0.01% |
112,439
+30,408
| +37% | +$80.3K |
|
|
APLT
2682
DELISTED
Applied Therapeutics
APLT
| $202K | ﹤0.01% |
43,338
-111,820
| -72% | -$529K |
|
|
AGNT
2683
AGNT Inc
AGNT
$734M
| $202K | ﹤0.01% |
17,900
-12,900
| -42% | -$141K |
|
|
ZTR
2684
Virtus Total Return Fund
ZTR
$339M
| $202K | ﹤0.01% |
37,008
+10,029
| +37% | +$54.3K |
|
2685
Invesco Energy Exploration & Production ETF
PXE
$79.8M
| $202K | ﹤0.01% |
+6,100
| New | +$210K |
|
2686
Zoom
ZM
$30.6B
| $202K | ﹤0.01% |
3,406
-2,842,439
| -100% | -$175M |
|
2687
CDW
CDW
$17B
| $201K | ﹤0.01% |
+900
| New | +$209K |
|
2688
Houlihan Lokey
HLI
$9.02B
| $200K | ﹤0.01% |
+1,484
| New | +$194K |
|
|
ATXS
2689
DELISTED
Astria Therapeutics
ATXS
| $195K | ﹤0.01% |
21,428
+1,137
| +6% | +$11.1K |
|
|
SGMO
2690
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $195K | ﹤0.01% |
543,194
-11,661
| -2% | -$6.3K |
|
2691
Sabesp
SBS
$18.7B
| $194K | ﹤0.01% |
+74,336
| New | +$218K |
|
|
DNB
2692
DELISTED
Dun & Bradstreet
DNB
| $190K | ﹤0.01% |
20,534
-56,591
| -73% | -$545K |
|
|
BASE
2693
DELISTED
Couchbase
BASE
| $190K | ﹤0.01% |
10,386
-6,514
| -39% | -$152K |
|
2694
Mineralys Therapeutics
MLYS
$2.41B
| $189K | ﹤0.01% |
16,134
+510
| +3% | +$6.42K |
|
|
CMBM
2695
DELISTED
Cambium Networks
CMBM
| $184K | ﹤0.01% |
65,956
-26,807
| -29% | -$94.1K |
|
2696
1-800-Flowers.com
FLWS
$258M
| $183K | ﹤0.01% |
19,249
+7,449
| +63% | +$69.9K |
|
2697
Alphatec Holdings
ATEC
$1.44B
| $183K | ﹤0.01% |
17,534
-43,412
| -71% | -$505K |
|
2698
Mayville Engineering Co
MEC
$617M
| $183K | ﹤0.01% |
10,978
-2,810
| -20% | -$42.5K |
|
2699
Turkcell
TKC
$4.79B
| $182K | ﹤0.01% |
24,024
+11,005
| +85% | +$72.3K |
|
2700
GSI Technology
GSIT
$258M
| $182K | ﹤0.01% |
68,501
-28,334
| -29% | -$92.3K |
|
Similar funds
VAM
Two Sigma Investments's Q2 2024 Portfolio in Review
As of Q2 2024, Two Sigma Investments held 3,471 positions worth $43.9B, up 3% from $42.6B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Two Sigma Investments's Q2 2024 filing shows 479 new, 1,205 increased, 1,169 reduced and 480 closed positions. Its largest new stake was Accenture: 270,632 shares worth $82.1M. The largest sale was Alphabet (Google) Class A, an estimated $282M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- Two Sigma Investments's largest Q2 2024 buy was Accenture: 270,632 shares worth $82.1M.
- Two Sigma Investments added most to Advanced Micro Devices in Q2 2024, an estimated $229M increase.
- Two Sigma Investments's biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $282M.
- Two Sigma Investments fully exited State Street Communication Services Select Sector SPDR ETF in Q2 2024, selling an estimated $186M.
- Two Sigma Investments's ten largest holdings make up 9.3% of its $43.9B portfolio in Q2 2024.
- Two Sigma Investments opened 479 new positions and closed 480 in Q2 2024.
- Two Sigma Investments's portfolio value rose 3% quarter-over-quarter to $43.9B.
Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.